Codiak BioSciences, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Codiak BioSciences, Inc. had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $16.40 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2022-11-03
- 2022-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $16.40M.
- 2022-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $19.90M.
- 2022-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $23.40M.
- 2021-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $20.30M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2022-09-30 | $16.40M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $19.90M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $23.40M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $20.30M 10-K · filed 2022-03-10 |
| 2021-09-30 | $24.50M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $25.30M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $24.60M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $14.50M 10-K · filed 2021-03-17 |
| 2020-09-30 | $16.00M 10-Q · filed 2020-11-19 |